• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Defensive·CELH
Held by 3 Gurus
Share

Celsius Holdings, Inc. Stocks

$ 29.79Last Updated 29.06.2026

Issuer Rating

3/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 7.50B

$ 29.79
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Latest news

26.02.2026 22:03

Are energizers the new coffee? Beverage maker Celsius soars 17% after report

23.02.2026 16:00

Morning in New York: tariff policy in the spotlight

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Celsius Holdings, Inc. is a global enterprise specializing in the development, production, promotion, and distribution of functional beverages and liquid nutritional supplements. Its extensive reach covers North America, Europe, Asia, and other international markets. The company's diverse product lineup includes CELSIUS Originals, offering both sparkling and still functional energy drinks. For a dietary supplement with an energy boost, they provide CELSIUS HEAT, available in carbonated varieties like apple jack'd, orangesicle, and inferno punch, as well as cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit. Muscle recovery is addressed with CELSIUS BCCA+ENERGY, a functional energy drink rich in branched-chain amino acids. Consumers seeking on-the-go options can find CELSIUS On-the-Go, which packages the active ingredients of their energy drinks as a powder in individual packets and canisters. Additionally, their CELSIUS Sweetened line features non-carbonated functional energy drinks in flavors such as sparkling grapefruit, cucumber lime, orange pomegranate, pineapple coconut, watermelon berry, and strawberries and cream. Celsius Holdings ensures its products reach a broad audience through a multifaceted distribution strategy, encompassing direct-to-store delivery partnerships, direct sales to various retailers including supermarkets, convenience stores, pharmacies, nutritional stores, and mass merchants, as well as sales to health clubs, spas, gyms, the military, and e-commerce channels. Founded in 2004 as Vector Ventures, Inc. before adopting its current name in January 2007, the company's headquarters are located in Boca Raton, Florida.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, overvalu

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of CELH is 56 and suggests 91.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.07.2026 20:33

"A Key Source of Value and Risk": Wall Street's Top Tech Optimist Assesses SpaceX

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

01.07.2026 18:59

Meta will launch a cloud infrastructure business. It will compete with Google and Nebius

01.07.2026 18:47

BlackRock is betting on scarce resources in AI supply chains. How should you build your portfolio?

01.07.2026 18:39

Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026